Testing Laboratories - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Testing industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Testing Laboratories - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Testing Laboratories
Corporate Insider Buy Sell Ratio (Insider Count) - Testing Laboratories
Testing Laboratories - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2019-12-10 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B M - Exercise D -8,000
2019-12-10 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B M - Exercise D 8.03 8,000
2019-12-10 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B S - Sale D 26.37 -8,000
2019-12-09 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0.96 2,000
2019-12-09 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0
2019-12-02 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 1.1906 65,000
2019-12-02 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0
2019-11-26 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0.991 10,000
2019-11-26 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0
2019-11-25 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0.9 50,000
2019-11-21 NEO / NeoGenomics, Inc. 4 JONES STEVEN C G - Gift D 24.53 -50,000
2019-11-21 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund S - Sale I 24.27 -23,162
2019-11-20 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund S - Sale I 24.35 -128,068
2019-11-19 NEO / NeoGenomics, Inc. 4 VAN OORT DOUGLAS M Conundrum Capital Partners S - Sale I 24.08 -187,500
2019-11-15 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER M - Exercise D -166
2019-11-15 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER M - Exercise D 8.03 166
2019-11-15 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER M - Exercise D 7.52 6,667
2019-11-15 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER M - Exercise D -6,667
2019-11-15 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER S - Sale D 23.45 -6,833
2019-11-13 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 5.24 75,000
2019-11-13 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0.01 75,000
2019-11-12 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE M - Exercise D 7.15 44,444
2019-11-12 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE M - Exercise D -44,444
2019-11-12 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE S - Sale D 23.15 -19,444
2019-11-08 NEO / NeoGenomics, Inc. 4 VAN OORT DOUGLAS M M - Exercise D -472,527
2019-11-08 NEO / NeoGenomics, Inc. 4 VAN OORT DOUGLAS M M - Exercise D 7.15 472,527
2019-11-08 NEO / NeoGenomics, Inc. 4 VAN OORT DOUGLAS M F - Taxes D -205,635
2019-11-07 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE S - Sale D 22.80 -4,000
2019-11-06 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE M - Exercise D 7.15 55,556
2019-11-06 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE M - Exercise D -55,556
2019-11-06 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE S - Sale D 22.82 -51,556
2019-11-01 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. S - Sale D 22.74 -35,801
2019-10-31 NEO / NeoGenomics, Inc. 4 Johnson Kevin C M - Exercise D 7.27 6,666
2019-10-31 NEO / NeoGenomics, Inc. 4 Johnson Kevin C M - Exercise D -6,666
2019-10-31 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D -96,166
2019-10-31 NEO / NeoGenomics, Inc. 4 Johnson Kevin C M - Exercise D 4.78 6,667
2019-10-31 NEO / NeoGenomics, Inc. 4 Johnson Kevin C M - Exercise D -3,017
2019-10-31 NEO / NeoGenomics, Inc. 4 Johnson Kevin C M - Exercise D 11.60 3,017
2019-10-31 NEO / NeoGenomics, Inc. 4 Johnson Kevin C M - Exercise D -8,333
2019-10-31 NEO / NeoGenomics, Inc. 4 Johnson Kevin C M - Exercise D -6,667
2019-10-31 NEO / NeoGenomics, Inc. 4 Johnson Kevin C M - Exercise D 9.11 8,333
2019-10-31 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D 8.03 96,166
2019-10-31 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. S - Sale D 23.11 -70,473
2019-09-25 DIGP / Hypha Labs, Inc. 4 Remenda Kyle A - Award D 500,000
2019-09-25 DIGP / Hypha Labs, Inc. 4/A Denkin Todd A - Award D 58,824
2019-09-25 DIGP / Hypha Labs, Inc. 4 Peterson Todd A A - Award D 147,059
2019-09-24 APDN / Applied DNA Sciences, Inc. 4 Bitzer John III X - Other I 0.54 196,661
2019-09-24 APDN / Applied DNA Sciences, Inc. 4 Bitzer John III X - Other I -106,197
2019-09-16 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0.3579 6,678
2019-09-13 APDN / Applied DNA Sciences, Inc. 4 Ferguson Elizabeth M. X - Other D 0.54 19,666
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)